Formulation and evaluation of a bioadhesive patch for buccal delivery of tizanidine

Hoogstraate, 1996, In vivo buccal delivery of fluorescein isothiocyanate-dextran 4400 with glycodeoxycholate as an absorption enhancer in pigs, J Pharm Sci, 85, 457, 10.1021/js950129k Patel, 2007, Design and characterization of chitosan-containing mucoadhesive buccal patches of propranolol hydrochloride, Acta Pharm, 57, 61, 10.2478/v10007-007-0005-9 Davis, 1982, Design and evaluation of sustained release formulations for oral and buccal administration, 1, 17 Owens, 2005, Development and evaluation of extended release bioadhesive sodium fluoride tablets, Int J Pharm, 288, 109, 10.1016/j.ijpharm.2004.09.017 Ishida, 1983, Highly viscous gel ointment containing carbopol for application to the oral mucosa, Chem Pharm Bull, 31, 4561, 10.1248/cpb.31.4561 Packer, 2001, Effect of Carvedilol on survival in severe chronic heart failure, N Engl J Med, 344, 1651, 10.1056/NEJM200105313442201 Anders, 1989, Evaluation of laminated mucoadhesive patches for buccal drug delivery, Int J Pharm, 49, 231, 10.1016/0378-5173(89)90347-5 Guo, 1994, Investigating the surface properties and bioadhesion of buccal patches, J Pharm Pharmacol, 46, 647, 10.1111/j.2042-7158.1994.tb03875.x Patel, 2007, Effect of hydrophilic polymers on buccoadhesive Eudragit patches of propranolol hydrochloride using factorial design, AAPS PharmSciTech, 8, 10.1208/pt0802045 Nance, 1994, Efficacy and safety of Tizanidine in the treatment of spasticity in patients with spinal cord injury North American tizanidine study group, Neurology, 44 A double blind, placebo-controlled trial of izanidine in the treatment of spasticity caused by multiple sclerosis (editorial). United Kingdom tizanidine trial group. Neurology 1994;44(11 Suppl 9):S70–8. Wagstaff, 1997, Tizanidine: a review of its pharmacology, clinical efficacy, and tolerability in the management of spasticity associated with cerebral and spinal disorders, Drugs, 53, 435, 10.2165/00003495-199753030-00007 Moffat, 2006 Shanker, 2009, Formulation and evaluation of bioadhesive buccal tablets of tizanidine hydrochloride tablets, AAPS PharmSciTech, 10, 530, 10.1208/s12249-009-9241-2 Giradkar, 2010, Design, development and in vitro evaluation of bioadhesive dosage form for buccal route, Int J Pharm Res Dev, 2, 1 Nafee, 2003, Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing, Int J Pharm, 264, 1, 10.1016/S0378-5173(03)00371-5 Remuñán-López, 1998, Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery, J Control Release, 55, 143, 10.1016/S0168-3659(98)00044-3 Verma, 2007, Evaluation of a mucoadhesive buccal patch for delivery of atenolol: in vitro screening of bioadhesion, J Pure Appl Microbiol, 1, 115 Nafee, 2003, Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride, Acta Pharm, 53, 199 Wang, 2004, Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment, Biomaterials, 25, 4279, 10.1016/j.biomaterials.2003.10.075 Gupta, 1992, Measurement of bioadhesion strength of mucoadhesive buccal tablet: design of an in vitro assembly, Ind Drugs, 30, 152 Nigalaye, 1990, Investigation of prolonged drug release from matrix formulations of chitosan, Drug Dev Ind Pharm, 16, 449, 10.3109/03639049009114897 Ebert, 1994, Mucosal delivery of macromolecules, J Control Release, 28, 37, 10.1016/0168-3659(94)90151-1 Li, 1997, Transmucosal delivery of oxytocin to rabbit using a mucoadhesive buccal patch, Pharm Dev Tech, 2, 265, 10.3109/10837459709031446